PTC Therapeutics Reaches Analyst Target Price
August 01, 2019 at 10:02 AM EDT
In recent trading, shares of PTC Therapeutics Inc (PTCT) have crossed above the average analyst 12-month target price of $48.00, changing hands for $48.17/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..